A vial of COVIran Barakat | |
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Inactivated |
| Clinical data | |
| Other names | COVIRAN کووایران برکت |
| Routes of administration | Intramuscular |
| ATC code |
|
| Legal status | |
| Legal status |
|
COVIran Barekat is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, part of the Barkat Pharmaceutical Group. It is an inactivated virus-based vaccine. Iranian authorities authorized its emergency use. It is the first locally developed COVID-19 vaccine to be approved for emergency use in the Middle East.